Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FD13R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,535
Award facts
- Contract value 100% obligated
- $15,534.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on September 26, 2025, provides Dupixent 300 mg/2 mL pen injections to the Defense Logistics Agency (DLA) through a firm fixed-price contract valued at $15,534.93. The award was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, which serves as a critical supplier for federal medical procurement needs across military and veteran healthcare systems. The delivery order is expected to be completed by September 29, 2025, and represents a non-competitive set-aside procurement.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's demonstrated capability to fulfill federal medical supply requirements through open competition, combined with its extensive portfolio of specialty medications and brand-name drugs, positions it as a key vendor for the Defense Health Agency and other government healthcare systems requiring reliable access to critical pharmaceuticals.
Quick answers
Who was awarded contract SPE2DB25FD13R?
SPE2DB25FD13R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FD13R worth?
The government has obligated $15,535 on SPE2DB25FD13R.
Is contract SPE2DB25FD13R an order under another contract?
Yes. SPE2DB25FD13R is a delivery order under SPE2DB20D2014, an indefinite delivery contract.
Was contract SPE2DB25FD13R competed?
The extent of competition for SPE2DB25FD13R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award